Cholesterol-linoleic acid liposomes induced extracellular vesicles secretion from immortalized adipose-derived mesenchymal stem cells for in vitro cell migration
Source abstract
Abstract
Extracellular vesicles (EVs) are small vesicles that are naturally released by cells and play a crucial role in cell-to-cell communication, tissue repair and regeneration. As naturally secreted EVs are limited, liposomes with different physicochemical properties, such as 1,2-dioleoyl-3-trimethylammonium propane (DOTAP) and linoleic acid (LA) with modifications have been formulated to improve EVs secretion for in vitro wound healing. Various analyses, including dynamic light scattering (DLS) and transmission electron microscopy (TEM) were performed to monitor the successful preparation of different types of liposomes. The results showed that cholesterol–LA liposomes significantly improved the secretion of EVs from immortalized adipose-derived mesenchymal stem cells (AD-MSCs) by 1.5-fold. Based on the cell migration effects obtained from scratch assay, both LA liposomal-induced EVs and cholesterol–LA liposomal-induced EVs significantly enhanced the migration of human keratinocytes (HaCaT) cell line. These findings suggested that LA and cholesterol–LA liposomes that enhance EVs secretion are potentially useful and can be extended for various tissue regeneration applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmacology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia
Department of Oral Biology and Biomedical Science, Faculty of Dentistry, MAHSA University, Selangor, Malaysia
Institute of Research Management and Services, Research and Innovation Management Complex, Universiti Malaya, Kuala Lumpur, Malaysia
Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur, Malaysia
Funding
Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia
References (100+)
Show source-provided references
1. 10.1016/j.freeradbiomed.2021.06.03010.1016/j.freeradbiomed.2021.06.030 ↗
2. 10.2147/IJN.S31035710.2147/IJN.S310357 ↗
3. 10.1186/s13287-018-0791-710.1186/s13287-018-0791-7 ↗
4. 10.3390/ijms2019481310.3390/ijms20194813 ↗
5. 10.3390/biom1005070710.3390/biom10050707 ↗
6. 10.1080/20013078.2018.153575010.1080/20013078.2018.1535750 ↗
7. 10.1016/j.molmed.2019.02.00310.1016/j.molmed.2019.02.003 ↗
8. Yang Q · J Clin Epigenet · 2016 · 2 · 13
9. 10.1038/s41392-020-00261-010.1038/s41392-020-00261-0 ↗
10. 10.1016/j.vph.2016.03.00510.1016/j.vph.2016.03.005 ↗
11. 10.1016/j.btre.2021.e0065810.1016/j.btre.2021.e00658 ↗
12. 10.1021/acs.langmuir.0c0249110.1021/acs.langmuir.0c02491 ↗
13. 10.1111/cpr.1223310.1111/cpr.12233 ↗
14. 10.7150/thno.4012210.7150/thno.40122 ↗
15. 10.3390/ijms2314798610.3390/ijms23147986 ↗
16. 10.3390/ijms23181052210.3390/ijms231810522 ↗
17. 10.1063/1.508712210.1063/1.5087122 ↗
18. 10.3390/ijms1603551710.3390/ijms16035517 ↗
19. 10.1152/physiol.00036.201610.1152/physiol.00036.2016 ↗
20. 10.22270/jddt.v4i2.76810.22270/jddt.v4i2.768 ↗
21. 10.1002/adhm.20210063910.1002/adhm.202100639 ↗
22. 10.1248/bpb.b17-0091910.1248/bpb.b17-00919 ↗
23. 10.1038/s41598-018-32861-w10.1038/s41598-018-32861-w ↗
24. 10.1016/j.prostaglandins.2020.10651910.1016/j.prostaglandins.2020.106519 ↗
25. 10.1038/s41598-023-31560-510.1038/s41598-023-31560-5 ↗
26. 10.3109/08982104.2012.70045910.3109/08982104.2012.700459 ↗
27. 10.1049/nbt2.1202810.1049/nbt2.12028 ↗
28. 10.1016/j.nucmedbio.2014.09.00110.1016/j.nucmedbio.2014.09.001 ↗
29. 10.1039/c8ra07601d10.1039/c8ra07601d ↗
30. 10.3390/molecules2523565510.3390/molecules25235655 ↗
31. Jalilian M · Iran J Pharm Res · 2021 · 20 · 327
32. 10.3390/antiox1203058810.3390/antiox12030588 ↗
33. 10.3390/v1502036410.3390/v15020364 ↗
34. Yefimova S · Exp Oncol · 2012 · 34 · 101
35. 10.3727/096504020X1603793318517010.3727/096504020X16037933185170 ↗
36. 10.1186/s13287-022-03008-610.1186/s13287-022-03008-6 ↗
37. 10.1208/s12249-010-9559-910.1208/s12249-010-9559-9 ↗
38. 10.1016/s0378-5173(03)00254-010.1016/s0378-5173(03)00254-0 ↗
39. 10.1016/j.jare.2010.05.00810.1016/j.jare.2010.05.008 ↗
40. 10.3390/molecules2304090710.3390/molecules23040907 ↗
41. 10.3390/pharmaceutics1211100110.3390/pharmaceutics12111001 ↗
42. 10.3390/pharmaceutics1307102310.3390/pharmaceutics13071023 ↗
43. 10.1016/j.jpba.2020.11364210.1016/j.jpba.2020.113642 ↗
44. 10.1016/B978-0-323-47720-8.00015-810.1016/B978-0-323-47720-8.00015-8 ↗
45. 10.3390/cells903066010.3390/cells9030660 ↗
46. 10.2147/IJN.S10905910.2147/IJN.S109059 ↗
47. 10.1007/s11095-017-2097-310.1007/s11095-017-2097-3 ↗
48. 10.2147/IJN.S30510610.2147/IJN.S305106 ↗
49. 10.1038/s41580-021-00375-510.1038/s41580-021-00375-5 ↗
50. 10.1016/j.biomaterials.2015.11.05610.1016/j.biomaterials.2015.11.056 ↗
51. 10.1152/advan.00029.200410.1152/advan.00029.2004 ↗
52. 10.1039/b809624d10.1039/b809624d ↗
53. 10.1016/j.bbamem.2016.08.00110.1016/j.bbamem.2016.08.001 ↗
54. 10.1016/j.jconrel.2019.04.02510.1016/j.jconrel.2019.04.025 ↗
55. 10.1016/j.ejpb.2022.01.00910.1016/j.ejpb.2022.01.009 ↗
56. 10.1007/s13346-017-0431-210.1007/s13346-017-0431-2 ↗
57. 10.1007/5584_2020_59510.1007/5584_2020_595 ↗
58. 10.3390/ijms2109324210.3390/ijms21093242 ↗
59. 10.3390/nano607012510.3390/nano6070125 ↗
60. 10.1091/mbc.E16-11-076410.1091/mbc.E16-11-0764 ↗
61. 10.3390/pharmaceutics1204037110.3390/pharmaceutics12040371 ↗
62. 10.1098/rsif.2014.045910.1098/rsif.2014.0459 ↗
63. 10.3390/biom1001004810.3390/biom10010048 ↗
64. 10.1016/j.biomaterials.2018.02.05210.1016/j.biomaterials.2018.02.052 ↗
65. 10.3109/21691401.2014.95363310.3109/21691401.2014.953633 ↗
66. 10.1080/17425247.2020.178323710.1080/17425247.2020.1783237 ↗
67. 10.3390/pharmaceutics1410219510.3390/pharmaceutics14102195 ↗
68. 10.1002/pep2.2404110.1002/pep2.24041 ↗
69. 10.7150/ntno.1979610.7150/ntno.19796 ↗
70. 10.1016/j.addr.2022.11448110.1016/j.addr.2022.114481 ↗
71. 10.3390/ph1408081110.3390/ph14080811 ↗
72. 10.1016/j.heliyon.2022.e0893410.1016/j.heliyon.2022.e08934 ↗
73. 10.1016/j.carbpol.2016.11.02110.1016/j.carbpol.2016.11.021 ↗
74. 10.1016/j.ejpb.2008.07.01110.1016/j.ejpb.2008.07.011 ↗
75. 10.3389/fcell.2018.0001810.3389/fcell.2018.00018 ↗
76. 10.1186/s40360-018-0230-510.1186/s40360-018-0230-5 ↗
77. 10.1016/j.bbamem.2014.05.02610.1016/j.bbamem.2014.05.026 ↗
78. 10.1016/j.bbamem.2004.02.00710.1016/j.bbamem.2004.02.007 ↗
79. 10.1016/j.conb.2013.08.00510.1016/j.conb.2013.08.005 ↗
80. 10.1111/jcmm.1347910.1111/jcmm.13479 ↗
81. 10.1016/j.ab.2013.12.00110.1016/j.ab.2013.12.001 ↗
82. 10.1002/adma.20200086610.1002/adma.202000866 ↗
83. 10.1021/acsomega.0c0158210.1021/acsomega.0c01582 ↗
84. 10.1038/s41598-017-14981-x10.1038/s41598-017-14981-x ↗
85. 10.1002/anie.20190992710.1002/anie.201909927 ↗
86. 10.3892/ijmm.2016.275910.3892/ijmm.2016.2759 ↗
87. 10.3390/v1210111710.3390/v12101117 ↗
88. 10.7150/thno.6909410.7150/thno.69094 ↗
89. 10.1016/j.ymeth.2015.03.01310.1016/j.ymeth.2015.03.013 ↗
90. 10.1016/j.biomaterials.2021.12131410.1016/j.biomaterials.2021.121314 ↗
91. 10.3390/cancers1309201410.3390/cancers13092014 ↗
92. 10.1371/journal.pone.019882010.1371/journal.pone.0198820 ↗
93. 10.1371/journal.pone.023199410.1371/journal.pone.0231994 ↗
94. 10.3389/fcvm.2017.0006310.3389/fcvm.2017.00063 ↗
95. 10.1089/wound.2012.041410.1089/wound.2012.0414 ↗
96. 10.1016/j.celrep.2022.11115510.1016/j.celrep.2022.111155 ↗
97. 10.3390/jcm806085510.3390/jcm8060855 ↗
98. 10.1002/jcp.2792210.1002/jcp.27922 ↗
99. 10.1007/s10561-014-9440-210.1007/s10561-014-9440-2 ↗
100. 10.1186/s13287-021-02287-910.1186/s13287-021-02287-9 ↗